Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
     422  Antimetabolites
     423  Antibiotics
     424  Plant extract preparations
     429  Miscellaneous
       4291  Other Antitumors
         D00068  Anhydrous ethanol (JP16); Alcohol (USP)
         D00094  Tretinoin (JAN/USP/INN)
         D00951  Medroxyprogesterone acetate (JAN/USP)
         D01370  Cladribine (JAN/USAN/INN)
         D03021  Azacitidine (JAN/USAN/INN)
         D02166  Mitoxantrone hydrochloride (JAN/USP)
         D00275  Cisplatin (JP16/USP/INN)
         D01363  Carboplatin (JP16/USP/INN)
         D01790  Oxaliplatin (JAN/USAN/INN)
         D00478  Procarbazine hydrochloride (JP16/USP)
         D02994  Rituximab (genetical recombination) (JAN); Rituximab (USAN/INN)
         D03257  Trastuzumab (genetical recombination) (JAN); Trastuzumab (INN)
         D03455  Cetuximab (genetical recombination) (JAN); Cetuximab (USAN/INN)
         D06409  Bevacizumab (genetical recombination) (JAN)
         D05350  Panitumumab (genetical recombination) (JAN); Panitumumab (USAN/INN)
         D09314  Ofatumumab (genetical recombination) (JAN); Ofatumumab (USAN/INN)
         D09587  Brentuximab vedotin (genetical recombination) (JAN); Brentuximab vedotin (USAN)
         D05446  Pertuzumab (genetical recombination) (JAN); Pertuzumab (USAN/INN)
         D01441  Imatinib mesilate (JAN); Imatinib mesylate (USAN)
         D01977  Gefitinib (JAN/USAN/INN)
         D04023  Erlotinib hydrochloride (JAN/USAN)
         D06402  Sunitinib malate (JAN/USAN)
         D06272  Sorafenib tosilate (JAN); Sorafenib tosylate (USAN)
         D06414  Dasatinib hydrate (JAN); Dasatinib (USAN)
         D04024  Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate (USAN)
         D06068  Temsirolimus (JAN/USAN/INN)
         D02714  Everolimus (JAN/USAN/INN)
         D05380  Pazopanib hydrochloride (JAN/USAN)
         D09733  Afatinib maleate (JAN); Afatinib dimaleate (USAN)
         D09731  Crizotinib (JAN/USAN/INN)
         D09960  Ruxolitinib phosphate (JAN/USAN)
         D10137  Regorafenib hydrate (JAN)
         D02997  L-Asparaginase (JAN); Asparaginase (USAN); Asparaginase Erwinia chrysanthemi (USAN)
         D00155  Pentostatin (JAN/USAN/INN)
         D02106  Arsenic trioxide (JP16/USAN)
         D03150  Bortezomib (JAN/USAN/INN)
         D06320  Vorinostat (JAN/USAN)
         D08914  Eribulin mesilate (JAN); Eribulin mesylate (USAN)
         D00966  Tamoxifen citrate (JP16/USP)
         D00967  Toremifene citrate (JAN/USAN)
         D01161  Fulvestrant (JAN/USAN/INN)
         D00586  Flutamide (JP16/USP/INN)
         D00961  Bicalutamide (JAN/USP/INN)
         D00960  Anastrozole (JAN/USAN/INN)
         D00964  Letrozole (JAN/USP/INN)
         D00963  Exemestane (JAN/USP/INN)
         D00754  Thalidomide (JAN/USP/INN)
         D09813  Lenalidomide hydrate (JAN)
         D04489  Ibritumomab tiuxetan (genetical recombination) (JAN); Ibritumomab tiuxetan (USAN/INN)
         D01404  Sobuzoxane (JAN)
         D01416  Nedaplatin (JAN/INN)
         D01418  Tamibarotene (JAN/INN)
         D01805  Aceglatone (JAN/INN)
         D06294  Miriplatin hydrate (JAN)
         D09761  Mogamulizumab (genetical recombination) (JAN); Mogamulizumab (USAN)
         D10218  Enzalutamide (JAN/USAN)
         D10316  Nivolumab (genetical recombination) (JAN); Nivolumab (USAN/INN)
         D10450  Alectinib hydrochloride (JAN)
D08AX08 V03AB16 V03AZ01
D10AD01 L01XX14
G03AC06 G03DA02 L02AB02
L01BB04
L01BC07
L01DB07
L01XA01
L01XA02
L01XA03
L01XB01
L01XC02
L01XC03
L01XC06
L01XC07
L01XC08
L01XC10
L01XC12
L01XC13
L01XE01
L01XE02
L01XE03
L01XE04
L01XE05
L01XE06
L01XE07
L01XE09
L01XE10 L04AA18
L01XE11
L01XE13
L01XE16
L01XE18
L01XE21
L01XX02
L01XX08
L01XX27
L01XX32
L01XX38
L01XX41
L02BA01
L02BA02
L02BA03
L02BB01
L02BB03
L02BG03
L02BG04
L02BG06
L04AX02
L04AX04
V10XX02
 
 
 
 
 
 
 
 
 
       4299  Others
       4290  Miscellaneous
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 5, 2014
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version